Allergic contact dermatitis



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Russian Dermatology describes irritant and allergic contact dermatitis. The latter one being immune associated is characterized by huge spectrum of clinical features demanding individual approaches to topical corticosteroid therapy. Hydrocortizone 17-butirate in the formulations of ointment, cream, Lipocream and Crelo allows effectively and safely solve therapeutic problems of topical treatment.

Full Text

Restricted Access

About the authors

N G Kochergin

First Moscow State Medical University

Email: nkocha@yandex.ru

References

  1. Кожные и венерические болезни. Под ред. О.Л. Иванова. М., «Шико». 2006, 226 с.
  2. Кочергин Н.Г., Петрунин Д.Д. Современный взгляд на проблему выбора лекарственной формы средств наружной терапии. Клин. дерматол. венерол. 2011, № 6, с. 78-85.
  3. Gip L., Verjans H.L. Hydrocortisone 17-butyrate 0,1% Lipocream vs betamethasone 17-valerate 0.1% cream in the treatment of patients with dry severe chronic eczema. Curr. Ther. Res. 1987, v. 41, p. 258-264.
  4. Guillet G., Nougue J. Etude comparative en double aveugle de deux dermocorticoides dans l’eczema aigu ou chronique 17-butyrate d’hydrocortisone crème epaisse versus dipropionate d’betamethasone pomade. Ther. Pharmacol. Clin. 1989, v. 7 (79), p. 10-17.
  5. Letawe C., Pierard-Franchimont C,. Pierard G.E. Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis. Eur. J. Clin. Pharmacol. 1996, v. 51, p. 253-257.
  6. Fowler J.F., Fransway A.F., Jackson J.M., Rohowsky N. Hydrocortisone butyrate 0,1% cream in the treatment of chronic dermatitis. Cutis. 2005, v. 75, p. 125-131.
  7. Berbis P., Hesse S., Privat Y. Essential fatty acids and the skin. Allerg. Immunol. 1990, v. 22 (6), p. 225-231.
  8. Niedner R., Degen A. Lokaltherapie der Psoriasis capilliti mit einer Hydrocortison-17- Butyrat-Emulsion im Vergleich zu einer Betamethason-17-Valerat-Lotion. Dtsch. Dermatol. 1993, v. 2, p. 198-200.
  9. Pierard G.E., Lachapelle J.M., Frentz G. et al. Hydrocortisone 17-butyrate topical emulsion (Locoid Crelo) in psoriasis. J. Eur. Acad. Dermatol. Venereol. 1996, v. 6, p.11-14.
  10. De Cuyper C., Degreef H.J., de la Brassinne M. et al. A randomized, single-blind study to compare hydrocortisone 17-butyrate 0,1% emulsion (HCB) versus betamethasone 17,21-dipropionate 0,05% lotion in the treatment of patients suffering from psoriasis of the scalp. J. Eur. Acad. Dermatol. Venerol. 1995. v. 5, Suppl. 1, p. 104-105.
  11. Jacoby H. A randomized, single-blind study to compare clinically and by squamometry the effect of Locoid (hydrocortisone 17-butyrate 0,1%) Crelo versus Diprosone (betamethasone 17,21-dipropionate 0,05%) lotion on the structure of stratum corneum in patients suffering from seborrhoeic dermatitis. Yamanouchi Doc. 1998, v. 701, p. 1-56.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2014



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies